VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RCEL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RCELAVITA Medical, Inc.
$5.00$124M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRCELQuarterly Financials

AVITA Medical, Inc. (RCEL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

AVITA Medical, Inc. (RCEL) quarterly income statement — complete revenue, gross profit & net income history

RCEL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue19.25M17.62M17.06M18.42M18.51M18.41M19.55M15.2M11.1M14.2M13.64M11.75M10.55M9.46M9.09M8.34M7.54M6.94M7.02M10.3M
Revenue Growth %3.98%-4.29%-12.71%21.21%66.73%29.67%43.25%29.29%5.25%50.13%50.08%41.01%39.94%36.32%29.52%-19.11%-13.99%35.92%38.74%165.77%
Cost of Goods Sold3.52M3.31M3.19M3.47M2.83M2.28M3.19M2.11M1.51M1.8M2.11M2.2M1.67M1.35M1.53M1.39M1.78M817K1.09M2.05M
COGS % of Revenue18.3%18.76%18.68%18.83%15.3%12.39%16.32%13.89%13.63%12.65%15.49%18.75%15.8%14.25%16.83%16.63%23.58%11.78%15.5%19.92%
Gross Profit15.73M14.31M13.88M14.95M15.68M16.13M16.36M13.08M9.59M12.4M11.53M9.55M8.88M8.11M7.56M6.95M5.76M6.12M5.93M8.25M
Gross Margin %81.7%81.24%81.32%81.17%84.7%87.61%83.68%86.11%86.37%87.35%84.51%81.25%84.2%85.75%83.17%83.37%76.42%88.22%84.5%80.08%
Gross Profit Growth %0.3%-11.26%-15.17%14.25%63.5%30.06%41.83%37.02%7.97%52.92%52.5%37.42%54.19%32.51%27.48%-15.78%-12.96%42.9%43.6%174.76%
Operating Expenses24.53M24.72M23.03M26.1M27.51M26.08M30.16M28.71M26.8M24.67M20.84M20.71M18.79M14.02M13.31M13.31M15.25M14.59M11.88M12.96M
OpEx % of Revenue127.43%140.32%134.97%141.69%148.58%141.71%154.31%188.93%241.33%173.81%152.72%176.24%178.14%148.24%146.39%159.7%202.25%210.4%169.25%125.73%
Selling, General & Admin18.9M19.03M19.28M20.98M21.22M21.23M24.73M23.82M21.6M17.97M16.66M16.17M14.84M11.66M10.41M10.8M12.36M9.85M8.87M9.42M
SG&A % of Revenue98.19%108.02%113%113.91%114.64%115.36%126.54%156.77%194.55%126.57%122.07%137.56%140.62%123.35%114.55%129.61%163.97%142.07%126.31%91.43%
Research & Development5.63M5.69M3.75M5.12M6.28M4.85M5.43M4.89M5.19M6.76M4.39M5.08M4.59M3.38M3.8M3.06M3.62M4.2M3.39M3.97M
R&D % of Revenue29.24%32.3%21.97%27.78%33.94%26.35%27.77%32.16%46.78%47.66%32.2%43.19%43.47%35.74%41.78%36.7%48.02%60.52%48.26%38.57%
Other Operating Expenses000000000-59K-212K-530K-627K-1000K-904K-551K-734K541K-374K-440K
Operating Income-8.8M-10.41M-9.15M-11.15M-11.83M-9.96M-13.81M-15.62M-17.21M-12.27M-9.31M-11.16M-9.91M-5.91M-5.75M-6.36M-9.49M-8.47M-5.95M-4.7M
Operating Margin %-45.73%-59.08%-53.65%-60.53%-63.88%-54.1%-70.63%-102.82%-154.95%-86.46%-68.2%-95%-93.94%-62.49%-63.22%-76.33%-125.84%-122.17%-84.74%-45.65%
Operating Income Growth %25.57%-4.53%33.7%28.65%31.26%18.87%-48.36%-39.94%-73.61%-107.74%-61.9%-75.5%-4.47%30.28%3.38%-35.25%-58.35%-50.49%41.76%63.88%
EBITDA-8.18M-9.71M-8.58M-10.6M-11.31M-9.55M-13.5M-15.42M-17M-12.09M-9.14M-11.02M-9.78M-5.78M-5.61M-6.22M-9.32M-8.32M-5.78M-4.53M
EBITDA Margin %-42.47%-55.11%-50.28%-57.53%-61.07%-51.87%-69.05%-101.48%-153.13%-85.14%-67%-93.75%-92.66%-61.11%-61.7%-74.69%-123.68%-119.91%-82.27%-43.95%
EBITDA Growth %27.68%-1.68%36.43%31.28%33.51%21%-47.63%-39.94%-73.93%-109.17%-62.96%-77.01%-4.85%30.53%2.86%-37.45%-60.1%-52.08%42.27%64.9%
D&A (Non-Cash Add-back)627K700K574K552K521K409K310K204K203K187K164K146K135K130K138K137K163K157K174K175K
EBIT-8.8M-10.41M-11.9M-8.66M-12.62M-10.27M-14.87M-14.01M-17.27M-5.93M-8.69M-10.36M-9.19M-5.32M-5.58M-6.25M-9.46M-8.46M-5.93M-4.7M
Net Interest Income-1.74M-1.25M-1.27M-1.25M-1.23M-1.3M-1.36M-1.35M-1.36M-1.12M15.56K10.51K5.98K8.81K9.38K5.79K12.45K-14.95K-9K-9K
Interest Income000000000015.56K10.51K5.98K8.81K9.38K5.79K12.45K-3.95K00
Interest Expense1.74M1.25M1.27M1.25M1.23M1.3M1.36M1.35M1.36M1.12M000000011K9K9K
Other Income/Expense-1.82M-1.23M-4.02M1.23M-2.02M-1.61M-2.43M264K-1.42M5.22M605K794K721K579K164K105K28K14K7K-7K
Pretax Income-10.62M-11.64M-13.17M-9.92M-13.85M-11.57M-16.23M-15.36M-18.63M-7.05M-8.7M-10.37M-9.19M-5.33M-5.58M-6.26M-9.46M-8.46M-5.94M-4.71M
Pretax Margin %-55.18%-66.06%-77.2%-53.84%-74.81%-62.86%-83.05%-101.09%-167.76%-49.69%-63.77%-88.24%-87.11%-56.36%-61.42%-75.07%-125.47%-121.97%-84.64%-45.72%
Income Tax-11K-17K15K4K8K19K-28K33K30K12K11K13K30K24K4K4K4K19K6K7K
Effective Tax Rate %0.1%0.15%-0.11%-0.04%-0.06%-0.16%0.17%-0.21%-0.16%-0.17%-0.13%-0.13%-0.33%-0.45%-0.07%-0.06%-0.04%-0.22%-0.1%-0.15%
Net Income-10.61M-11.62M-13.19M-9.92M-13.86M-11.59M-16.2M-15.39M-18.66M-7.07M-8.71M-10.38M-9.22M-5.35M-5.59M-6.26M-9.46M-8.48M-5.95M-4.72M
Net Margin %-55.12%-65.97%-77.29%-53.86%-74.86%-62.96%-82.91%-101.3%-168.03%-49.77%-63.85%-88.35%-87.39%-56.62%-61.46%-75.12%-125.52%-122.25%-84.73%-45.79%
Net Income Growth %23.44%-0.28%18.62%35.56%25.72%-64.03%-86.01%-48.24%-102.36%-31.98%-55.91%-65.85%2.57%36.87%6.05%-32.7%-57.8%-50.31%41.84%63.47%
Net Income (Continuing)-10.61M-11.62M-13.19M-9.92M-13.86M-11.59M-16.2M-15.39M-18.66M-7.07M-8.71M-10.38M-9.22M-5.35M-5.59M-6.26M-9.46M-8.48M-5.95M-4.72M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.35-0.38-0.46-0.38-0.53-0.44-0.62-0.60-0.73-0.28-0.53-0.62-0.55-0.31-0.35-0.36-0.51-0.25-0.24-0.19
EPS Growth %33.96%13.64%25.81%36.67%27.4%-58.84%-16.98%3.23%-32.73%10.65%-51.43%-72.22%-7.84%-24%-45.83%-89.47%-45.71%26.47%64.18%78.41%
EPS (Basic)-0.35-0.38-0.46-0.38-0.53-0.44-0.62-0.60-0.73-0.28-0.53-0.62-0.55-0.31-0.35-0.36-0.51-0.25-0.24-0.19
Diluted Shares Outstanding305.41M30.38M28.39M26.37M26.25M26.15M25.98M25.76M25.64M25.48M25.4M25.24M25.2M25.08M25.01M24.97M24.94M24.36M24.91M24.86M
Basic Shares Outstanding305.41M30.38M28.39M26.37M26.25M26.15M25.98M25.76M25.64M25.48M25.4M25.24M25.2M25.08M25.01M24.97M24.94M24.36M24.91M24.86M
Dividend Payout Ratio--------------------